Prognostic Value of p53 and/or p16 Alterations in Ewing Sarcoma
OBJECTIVES:
Primary
- Determine if mutation of p53, and/or deletion of the p16 locus, have prognostic value
in patients with Ewing sarcoma.
Secondary
- Estimate the incidence of p53 mutation in Ewing sarcoma samples collected from COG
studies.
- Estimate the incidence of p16 deletions in Ewing sarcoma samples collected from COG
studies.
- Prepare and archive amplified genomic DNA from Ewing sarcoma samples collected from COG
studies for future biologic analysis.
OUTLINE: This is a multicenter study.
Previously archived tumor samples are analyzed for p53 mutations and p16 deletion by
immunohistochemistry, FISH, PCR, and DNA sequencing.
Observational
N/A
Event-free survival
No
Stephen Lessnick, MD, PhD
Study Chair
University of Utah
United States: Federal Government
CDR0000614591
NCT00898053
September 2008
Name | Location |
---|